DP10017-Randomized, double-blind, placebo-controlled Phase III study of APD421 (amisulpride for IV injection) as combination prophylaxis against post-operative nausea and vomiting in high-risk patient
Clinical Trial Grant
Administered By
Anesthesiology, Women's
Awarded By
Premier Research
Start Date
March 1, 2015
End Date
February 28, 2018
Administered By
Anesthesiology, Women's
Awarded By
Premier Research
Start Date
March 1, 2015
End Date
February 28, 2018